v3.26.1
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]                
Net sales $ 338,357     $ 390,351     $ 1,090,360 $ 1,196,432
Adjusted EBITDA 26,252     33,615     70,266 93,883
Depreciation and amortization (12,484)     (10,455)     (39,044) (32,902)
Equity in net loss of equity-method investees (21)     (966)     (327) (1,709)
Interest expense, net (12,515)     (11,096)     (39,723) (36,084)
(Provision) benefit for income taxes (759)     505     (1,889) (5,746)
Stock-based compensation, net (1,138)     (2,973)     (4,192) (9,422)
Unrealized currency losses (219)     (1,137)     (623) (707)
Proceeds from insurance claim 0     0     25,900 0
Certain litigation expenses, net (2,519)     (407)     (3,164) (2,254)
Acquisitions, divestitures and other                
(Loss) gain on sale of assets (50,529)     106     (48,501) 2,202
Transaction and integration costs, net (1,553)     151     (4,735) (574)
Impairment charges                
Goodwill impairment (31,018)     (110,251)     (150,926) (201,518)
Long-lived asset and intangibles impairment (15,047)     (24,012)     (26,964) (42,029)
Net loss (106,343) $ (116,006) $ (20,625) (134,588) $ (103,975) $ (19,663) (242,974) (258,226)
Productivity and transformation costs                
Restructuring activities                
Restructuring activities (4,066)     (7,289)     (17,519) (16,497)
Plant closure related costs, net                
Restructuring activities                
Restructuring activities (727)     5     (1,533) (1,229)
Warehouse/manufacturing consolidation and other costs, net                
Restructuring activities                
Restructuring activities 0     (384)     0 (384)
North America                
Impairment charges                
Goodwill impairment             (38,495) (201,518)
International                
Impairment charges                
Goodwill impairment             (112,431)  
Operating Segments                
Segment Reporting Information [Line Items]                
Net sales 338,357     390,351     1,090,360 1,196,432
Cost of sales, adjusted to exclude restructuring activities (267,371)     (305,109)     (872,649) (934,941)
Marketing expense (12,159)     (16,268)     (39,015) (44,862)
Other selling, general and administrative expenses, adjusted to exclude restructuring activities and depreciation and amortization (34,211)     (39,724)     (113,274) (130,274)
Depreciation and amortization and other adjustments 12,135     10,222     30,802 33,779
Adjusted EBITDA 36,751     39,472     96,224 120,134
Operating Segments | North America                
Segment Reporting Information [Line Items]                
Net sales 171,495     222,407     573,236 682,836
Cost of sales, adjusted to exclude restructuring activities (131,330)     (172,637)     (445,700) (527,669)
Marketing expense (9,884)     (11,360)     (27,599) (30,949)
Other selling, general and administrative expenses, adjusted to exclude restructuring activities and depreciation and amortization (16,614)     (24,742)     (63,907) (81,732)
Depreciation and amortization and other adjustments 3,504     3,638     9,061 12,586
Adjusted EBITDA 17,171     17,306     45,091 55,072
Operating Segments | International                
Segment Reporting Information [Line Items]                
Net sales 166,862     167,944     517,124 513,596
Cost of sales, adjusted to exclude restructuring activities (136,041)     (132,472)     (426,949) (407,272)
Marketing expense (2,275)     (4,908)     (11,416) (13,913)
Other selling, general and administrative expenses, adjusted to exclude restructuring activities and depreciation and amortization (17,597)     (14,982)     (49,367) (48,542)
Depreciation and amortization and other adjustments 8,631     6,584     21,741 21,193
Adjusted EBITDA 19,580     22,166     51,133 65,062
Corporate and Other                
Segment Reporting Information [Line Items]                
Adjusted EBITDA $ (10,499)     $ (5,857)     $ (25,958) $ (26,251)